Nancy E. Kemeny
Impact in
- Hepatology top 0.02%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
Papers in
- Hepatology 182
- Hepatocellular Carcinoma Treatment and Prognosis 180
- Oncology 175
- Colorectal Cancer Treatments and Studies 114
- Pancreatic and Hepatic Oncology Research 37
- Cancer Treatment and Pharmacology 30
- Co-authors
- Yuman Fong (72 shared papers)William R. Jarnagin (101 shared papers)Mithat Gönen (72 shared papers)Ronald P. DeMatteo (63 shared papers)Leonard B. Saltz (68 shared papers)Leslie H. Blumgart (29 shared papers)Michael I. D’Angelica (76 shared papers)Michael I. D’Angelica (36 shared papers)
- Journals
- Journal of Clinical Oncology (83 papers)Cancer (45 papers)Annals of Surgical Oncology (30 papers)Journal of Surgical Oncology (12 papers)Annals of Surgery (11 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Nancy E. Kemeny
373 papers receiving 25.6k citations
Nancy E. Kemeny's Hit Papers
Peers
Comparison fields: 5 of 158
- Hepatology 8.8k
- Oncology 12.0k
- Cancer Research 2.1k
- Pulmonary and Respiratory Medicine 4.4k
- Surgery 5.5k
Countries citing papers authored by Nancy E. Kemeny
This map shows the geographic impact of Nancy E. Kemeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Kemeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Kemeny more than expected).
Fields of papers citing papers by Nancy E. Kemeny
This network shows the impact of papers produced by Nancy E. Kemeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Kemeny. The network helps show where Nancy E. Kemeny may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy E. Kemeny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 387 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress Hit paper breakdown → | 1994 | 1318 |
| 2 | ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer Hit paper breakdown → | 2006 | 1245 |
| 3 | Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure Hit paper breakdown → | 2007 | 933 |
| 4 | Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry Hit paper breakdown → | 2005 | 888 |
| 5 | Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer Hit paper breakdown → | 1999 | 722 |
| 6 | 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology* Hit paper breakdown → | 2001 | 707 |
| 7 | Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2008 | 678 |
| 8 | Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers Hit paper breakdown → | 1996 | 591 |
| 9 | Symptom prevalence, characteristics and distress in a cancer population Hit paper breakdown → | 1994 | 544 |
| 10 | Intrahepatic or Systemic Infusion of Fluorodeoxyuridine in Patients with Liver Metastases from Colorectal Carcinoma Hit paper breakdown → | 1987 | 527 |
| 11 | Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention Hit paper breakdown → | 2018 | 389 |
| 12 | 2007 | 351 | |
| 13 | 2006 | 325 | |
| 14 | 1996 | 302 | |
| 15 | Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center Hit paper breakdown → | 2015 | 291 |
| 16 | 2009 | 279 | |
| 17 | 2012 | 271 | |
| 18 | 2014 | 267 | |
| 19 | 2003 | 238 | |
| 20 | 2009 | 235 |
About Nancy E. Kemeny
Nancy E. Kemeny is a scholar working on Hepatology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 387 papers that have together received 26.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (180 papers), Colorectal Cancer Treatments and Studies (114 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (54 papers), Pancreatic and Hepatic Oncology Research (37 papers), Cancer Treatment and Pharmacology (30 papers), Colorectal and Anal Carcinomas (22 papers), Genetic factors in colorectal cancer (20 papers) and Lung Cancer Treatments and Mutations (19 papers). The work is most often cited by research in Hepatology (8.8k citations), Oncology (12.0k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (4.4k citations) and Surgery (5.5k citations). Nancy E. Kemeny has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Yuman Fong, William R. Jarnagin, Mithat Gönen, Ronald P. DeMatteo, Leonard B. Saltz, Leslie H. Blumgart, Michael I. D’Angelica, Michael I. D’Angelica, Robert C. Bast and Gershon Y. Locker. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Surgical Oncology, Journal of Surgical Oncology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.